Literature DB >> 28848811

Defining COPD-Related Comorbidities, 2004-2014.

Carlos H Martinez1, David M Mannino2, Miguel J Divo3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a disease of aging in combination with genetic, environmental, and behavioral risk factors. Aging and many of these risk factors are shared with other diseases, and, as a result, it is not surprising that patients with COPD often have coexistent diseases. This review of COPD comorbidities uses a framework in which coexistent diseases are considered important comorbidities if they are more frequent, have more severe consequences, influence the progression and outcomes of COPD, or are clustered together into proposed phenotypes, supplemented by a framework in which certain comorbidities are expected to share specific pathogenic mechanisms. This review explores classic COPD comorbidities such as cardiovascular disease, cachexia and sleep apnea, but also looks at more recently described comorbidities, such as gastroesophageal reflux, osteoporosis and depression/anxiety.

Entities:  

Keywords:  cardiovascular disease; chronic illness; chronic obstructive pulmonary disease; comorbidity

Year:  2014        PMID: 28848811      PMCID: PMC5560476          DOI: 10.15326/jcopdf.1.1.2014.0119

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  129 in total

Review 1.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

2.  Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure.

Authors:  Florian Kollert; Andrea Tippelt; Carolin Müller; Rudolf A Jörres; Christine Porzelius; Michael Pfeifer; Stephan Budweiser
Journal:  Respir Care       Date:  2012-12-04       Impact factor: 2.258

3.  Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

Authors:  Vincent S Fan; Scott D Ramsey; Nicholas D Giardino; Barry J Make; Charles F Emery; Phillip T Diaz; Joshua O Benditt; Zab Mosenifar; Robert McKenna; Jeffrey L Curtis; Alfred P Fishman; Fernando J Martinez
Journal:  Arch Intern Med       Date:  2007-11-26

4.  The association of inhaled corticosteroid use with serum glucose concentration in a large cohort.

Authors:  Christopher G Slatore; Chris L Bryson; David H Au
Journal:  Am J Med       Date:  2009-05       Impact factor: 4.965

5.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Authors:  Mette Thomsen; Truls Sylvan Ingebrigtsen; Jacob Louis Marott; Morten Dahl; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

6.  Depressive symptoms as predictors of mortality in patients with COPD.

Authors:  Jacob N de Voogd; Johan B Wempe; Gerard H Koëter; Klaas Postema; Eric van Sonderen; Adelita V Ranchor; James C Coyne; Robbert Sanderman
Journal:  Chest       Date:  2008-11-24       Impact factor: 9.410

7.  The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Authors:  Kerry Schnell; Carlos O Weiss; Todd Lee; Jerry A Krishnan; Bruce Leff; Jennifer L Wolff; Cynthia Boyd
Journal:  BMC Pulm Med       Date:  2012-07-09       Impact factor: 3.317

8.  Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Irena Sarc; Tina Jeric; Kristina Ziherl; Mitja Kosnik; Stefan D Anker; Stanislav Suskovic
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-01       Impact factor: 12.910

9.  Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study.

Authors:  Jinhee Kim; Jin Hwa Lee; Yuri Kim; Kyungjoo Kim; Yeon-Mok Oh; Kwang Ha Yoo; Chin Kook Rhee; Hyoung Kyu Yoon; Young Sam Kim; Yong Bum Park; Sei Won Lee; Sang Do Lee
Journal:  BMC Pulm Med       Date:  2013-08-09       Impact factor: 3.317

10.  Increased risk and related factors of depression among patients with COPD: a population-based cohort study.

Authors:  Tzung-Yi Tsai; Hanoch Livneh; Ming-Chi Lu; Pang-Yau Tsai; Pei-Chun Chen; Fung-Chang Sung
Journal:  BMC Public Health       Date:  2013-10-19       Impact factor: 3.295

View more
  9 in total

Review 1.  The Launch of a New COPD Journal.

Authors:  James D Crapo; Peter J Barnes; Paul W Jones; Barry J Make; David M Mannino
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

2.  Pulmonary Dysfunction Augmenting Bacterial Aerosols in Leather Tanneries of Punjab, Pakistan.

Authors:  Fiza Sarwar; Khan Alam; Chung Wai Chow; Muhammad Saeed; Riffat Naseem Malik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-27

3.  Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.

Authors:  Allison A Lambert; Nirupama Putcha; M Bradley Drummond; Aladin M Boriek; Nicola A Hanania; Victor Kim; Gregory L Kinney; Merry-Lynn N McDonald; Emily P Brigham; Robert A Wise; Meredith C McCormack; Nadia N Hansel
Journal:  Chest       Date:  2016-08-25       Impact factor: 9.410

4.  Risk factors associated with physical and mental distress in people who report a COPD diagnosis: latent class analysis of 2016 behavioral risk factor surveillance system data.

Authors:  Michael Stellefson; Samantha R Paige; Adam E Barry; Min Qi Wang; Avery Apperson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-04-10

Review 5.  Osteoporosis among Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-analysis of Prevalence, Severity, and Therapeutic Outcomes.

Authors:  Ahmad Naoras Bitar; Syed Azhar Syed Sulaiman; Irfhan Ali Hyder Ali; Irfanullah Khan; Amer Hayat Khan
Journal:  J Pharm Bioallied Sci       Date:  2019 Oct-Dec

6.  The Impact of Interprofessional Monitoring and Education on the Usage of Systemic Glucocorticoids in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Medication Use Review.

Authors:  Nicholas L Biondi; Michael M Samiratedu; Emily Highsmith; Adam Rosenblum; Kerri McGrady; Savannah Knepper; Riley Bowers
Journal:  Cureus       Date:  2019-11-24

7.  Facebook Groups on Chronic Obstructive Pulmonary Disease: Social Media Content Analysis.

Authors:  Avery Apperson; Michael Stellefson; Samantha R Paige; Beth H Chaney; J Don Chaney; Min Qi Wang; Arjun Mohan
Journal:  Int J Environ Res Public Health       Date:  2019-10-09       Impact factor: 3.390

8.  Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).

Authors:  Hisamitsu Omori; Noritaka Higashi; Takeshi Nawa; Toshiki Fukui; Toshihiko Kaise; Takeo Suzuki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-23

Review 9.  Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review.

Authors:  Natasha Cordeiro Dos Santos; Marc Miravitlles; Aquiles Assunção Camelier; Victor Durier Cavalcanti de Almeida; Roberto Rodrigues Bandeira Tosta Maciel; Fernanda Warken Rosa Camelier
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-05-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.